Paper36033713
Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics.
Al-Natour MA and 4 others. ACS Omega, 2022. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics. Papers, record 36033713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36033713
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30706066 | Investigating the intracellular effects of hyperbranched polycation-DNA complexes on lung cancer cells using LC-MS-based metabolite profiling. | Mol Omics | 2019 | https://conductscience.org/library/papers/30706066 | PubMed |
| 2 | 20128631 | A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. | Crit Rev Toxicol | 2010 | https://conductscience.org/library/papers/20128631 | PubMed |
| 3 | 18216768 | Membrane lipids: where they are and how they behave. | Nat Rev Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18216768 | PubMed |
| 4 | 17334670 | Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. | Inflamm Res | 2007 | https://conductscience.org/library/papers/17334670 | PubMed |
| 5 | 23498118 | A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusion. | Anal Chim Acta | 2013 | https://conductscience.org/library/papers/23498118 | PubMed |
| 6 | 25130606 | THP-1 cell line: an in vitro cell model for immune modulation approach. | Int Immunopharmacol | 2014 | https://conductscience.org/library/papers/25130606 | PubMed |
| 7 | 32432092 | PLGA-Based Drug Delivery Systems for Remotely Triggered Cancer Therapeutic and Diagnostic Applications. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/32432092 | PubMed |
| 8 | 7899246 | Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. | Pharm Res | 1994 | https://conductscience.org/library/papers/7899246 | PubMed |
| 9 | 24486260 | Targeting a rare amyloidotic disease through rationally designed polymer conjugates. | J Control Release | 2014 | https://conductscience.org/library/papers/24486260 | PubMed |
| 10 | 21793675 | Nanomaterial cell interactions: are current in vitro tests reliable? | Nanomedicine (Lond) | 2011 | https://conductscience.org/library/papers/21793675 | PubMed |
| 11 | 31369234 | Cellular Targeting of Bispecific Antibody-Functionalized Poly(ethylene glycol) Capsules: Do Shape and Size Matter? | ACS Appl Mater Interfaces | 2019 | https://conductscience.org/library/papers/31369234 | PubMed |
| 12 | 18534704 | Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. | J Control Release | 2008 | https://conductscience.org/library/papers/18534704 | PubMed |
| 13 | 21401061 | PeakML/mzMatch: a file format, Java library, R library, and tool-chain for mass spectrometry data analysis. | Anal Chem | 2011 | https://conductscience.org/library/papers/21401061 | PubMed |
| 14 | 29654580 | Quality Control and Validation Issues in LC-MS Metabolomics. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29654580 | PubMed |
| 15 | 32936613 | Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting. | ACS Nano | 2020 | https://conductscience.org/library/papers/32936613 | PubMed |
| 16 | 33673519 | Phospholipid-Gold Nanorods Induce Energy Crisis in MCF-7 Cells: Cytotoxicity Evaluation Using LC-MS-Based Metabolomics Approach. | Biomolecules | 2021 | https://conductscience.org/library/papers/33673519 | PubMed |
| 17 | 24039616 | Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). | Metabolomics | 2007 | https://conductscience.org/library/papers/24039616 | PubMed |
| 18 | 26344855 | Insights into the impact of silver nanoparticles on human keratinocytes metabolism through NMR metabolomics. | Arch Biochem Biophys | 2016 | https://conductscience.org/library/papers/26344855 | PubMed |
| 19 | 19040729 | Highly sensitive feature detection for high resolution LC/MS. | BMC Bioinformatics | 2008 | https://conductscience.org/library/papers/19040729 | PubMed |
| 20 | 19887611 | Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. | Cancer Res | 2009 | https://conductscience.org/library/papers/19887611 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41254319 | Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with a Folate Receptor-α (FRα) Ligand, Pemetrexed. | Pharm Res | 2025 | https://conductscience.org/library/papers/41254319 | PubMed |
| 39254438 | Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery. | Bioconjug Chem | 2024 | https://conductscience.org/library/papers/39254438 | PubMed |
| 39035697 | Study on the metabolic effects of hexavalent chromium [Cr (VI)] on rat astrocytes using un-targeted metabolomics. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39035697 | PubMed |
| 37587394 | Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study. | Pharmacol Rep | 2023 | https://conductscience.org/library/papers/37587394 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36033713
GET https://conductscience.org/api/papers/v1/36033713/references?page=2